Trials / Terminated
TerminatedNCT03255798
A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent Supra
A Prospective Evaluation of Mild to Moderate Open-Angle Glaucoma Subjects Treated With Two Second Generation Micro-bypass Stents and One Suprachoroidal Stent
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Glaukos Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective Evaluation of Open-Angle Glaucoma Subjects treated with two second generation iStents and one iStent Supra
Detailed description
Prospective Evaluation of Mild to Moderate Open-Angle Glaucoma Subjects treated with Two Second Generation Microbypass Stents and One Suprachoroidal Stent
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | G2 and G3 | Two iStent inject devices and one iStent supra device |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2019-06-06
- Completion
- 2019-06-06
- First posted
- 2017-08-21
- Last updated
- 2022-09-09
Locations
1 site across 1 country: Germany
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03255798. Inclusion in this directory is not an endorsement.